Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-di
about
Advance of prophylactic cranial irradiation in lung cancerTherapeutic procedure in small cell lung cancerThe Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature.Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 9Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centresPotential toxicities of prophylactic cranial irradiation.Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysisThe use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis.Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer.Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceCogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933.Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy.Brain metastasis as an isolated late recurrence in small-cell lung cancerResearch progress in the treatment of small cell lung cancer.The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom?Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review.Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment.Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases.Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy.Prophylactic cranial irradiation: recent outcomes and innovations.Treatment of radiation-induced cognitive decline.The Role of Radiotherapy in Small Cell Lung Cancer: a Revisit.Recent developments in radiotherapy for small-cell lung cancer: a review by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society).Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer.A pilot study using dynamic contrast enhanced-MRI as a response biomarker of the radioprotective effect of memantine in patients receiving whole brain radiotherapyProphylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy.Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study.Treatment of limited disease small cell lung cancer: the multidisciplinary team.Isolated solitary brain metastasis as a relapse of small cell lung cancer.
P2860
Q26823992-50CF134E-5430-4BAF-8BB7-A58C6A633191Q26861330-5FB125EE-82C5-466A-8D1D-E05F0AE80B2DQ33799729-5A413EE1-BD9B-4D34-8F22-F402DA8C002CQ34551025-7C56453D-2ACE-4C52-98FC-6ADE20062201Q34653756-1024AF11-442E-47D6-9175-8E1C776D72F1Q34666843-1CFCF5B6-1A97-4716-96EF-5ED8640F5E9FQ34854124-359EABB0-727F-47F0-B857-2FECC5CCC774Q34981488-09222186-3E09-4D1B-8721-CF1EC479DF25Q35200326-F6F63191-96A2-47AF-99BA-7CF542DECF1DQ35384553-FA230404-C933-4242-A595-1C76698A6D8EQ35828015-C2588A03-00D1-439E-987B-B5192BFD9DB7Q35983692-551D5E87-3A5D-449B-A424-DD8D905D4612Q36162228-7B60707D-59EC-4EA5-A450-FCC6660E8F1FQ36623209-6635E30E-CA76-4FD8-AD69-3E4E78FCA6ACQ36689055-EDDD659F-6B56-49FB-B0AF-F6BF0884517FQ36698177-36FA6E66-1472-4FAB-B992-21FF99DFBB23Q36962582-D74632E9-1E67-4B38-8AE8-4E3B95C00F8DQ36965962-17BF23CC-116D-4133-A501-404308878CA9Q37187732-DD3CACDE-0845-4CA0-8F83-3B7EAB3D9889Q37190242-D26AA9DE-6F42-40B0-97B3-01A0ACEB4027Q37572480-955C0584-85AB-4566-866B-A26658E71960Q37604301-0C98F0E2-4D6E-47B1-8FEC-DFC0F5DE9954Q37958051-6AE2CE06-AFBB-426D-B76F-8813437AD7B0Q38002472-2A24A16F-6E32-4E0E-815D-1F097B2AA4F5Q38010804-B9B3C121-F2AA-4373-8FE5-C2AB6D3DC1D0Q38013846-A0CB922C-942F-4457-A40D-1696927378AAQ38110196-47E78BE4-CC3E-4B89-9C83-F60F36339DD1Q38139324-B15FEF35-FF35-4906-81D1-725C32981ADBQ38233180-0283A956-6FA1-4932-9ABC-B8DBB8D780A4Q38250246-71F3572E-19EB-42BA-9050-D8FD318D56BFQ38527053-5397DA85-7562-44E5-B0BF-0D8A6B10B285Q38690406-26433474-A863-441C-B88C-910F063D0B19Q38907233-5D5424C5-8E92-4623-AA04-51593BB6CFBAQ39645980-EEB98025-88B2-45E6-A6D9-56F30071FEB1Q39719201-8EA6ED46-CC48-4F38-A179-B72494FFA39DQ40386962-0EBF92D5-0A35-4AC3-B61C-5F4BE76EF8F8Q40482799-0F5335DD-2582-46D5-BC31-9C577BBF98AEQ41067539-2339AB7B-7EEB-406B-91E9-815CEB755551Q41357983-10FDC77D-345F-4CDC-8B1C-07BC830F1E7FQ41946440-B0A13105-EB08-47F0-BEC1-CE4E7E1BA0CC
P2860
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-di
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Primary analysis of a phase II ...... e for patients with limited-di
@ast
Primary analysis of a phase II ...... e for patients with limited-di
@en
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group
@nl
type
label
Primary analysis of a phase II ...... e for patients with limited-di
@ast
Primary analysis of a phase II ...... e for patients with limited-di
@en
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group
@nl
prefLabel
Primary analysis of a phase II ...... e for patients with limited-di
@ast
Primary analysis of a phase II ...... e for patients with limited-di
@en
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group
@nl
P2093
P2860
P921
P1476
Primary analysis of a phase II ...... e for patients with limited-di
@en
P2093
Aaron H Wolfson
Benjamin Movsas
Cecile Le Pechoux
Christina Meyers
Gregory M M Videtic
Kyounghwa Bae
Yolanda I Garces
P2860
P356
10.1016/J.IJROBP.2010.05.013
P407
P577
2010-08-26T00:00:00Z